Cargando…
Morin Hydrate Reverses Cisplatin Resistance by Impairing PARP1/HMGB1-Dependent Autophagy in Hepatocellular Carcinoma
Chemoresistance is a major obstacle that limits the benefits of cisplatin-based chemotherapy in various cancers, including hepatocellular carcinoma. De-regulation of the poly(ADP-ribose) polymerase 1 (PARP1)/high-mobility group box 1 (HMGB1) signaling pathway has been proposed as an important mechan...
Autores principales: | Singh, Mahendra Pal, Cho, Hee Jun, Kim, Jong-Tae, Baek, Kyoung Eun, Lee, Hee Gu, Kang, Sun Chul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678360/ https://www.ncbi.nlm.nih.gov/pubmed/31311167 http://dx.doi.org/10.3390/cancers11070986 |
Ejemplares similares
-
Morin Hydrate Sensitizes Hepatoma Cells and Xenograft Tumor towards Cisplatin by Downregulating PARP-1-HMGB1 Mediated Autophagy
por: Pal Singh, Mahendra, et al.
Publicado: (2020) -
Morin hydrate attenuates the acrylamide-induced imbalance in antioxidant enzymes in a murine model
por: SINGH, MAHENDRA PAL, et al.
Publicado: (2015) -
Determination of solubility, stability and degradation kinetics of morin hydrate in physiological solutions
por: Jangid, Ashok Kumar, et al.
Publicado: (2018) -
Morin Hydrate Encapsulation and Release from Mesoporous Silica Nanoparticles for Melanoma Therapy
por: Cunha, Catarina, et al.
Publicado: (2023) -
Morin Induces Heme Oxygenase-1 via ERK-Nrf2 Signaling Pathway
por: Park, Ji Young, et al.
Publicado: (2013)